Literature DB >> 25990743

Update on blood pressure control and renal outcomes in diabetes mellitus.

Mark Henry Joven1, Robert J Anderson.   

Abstract

Diabetic nephropathy (DN) is associated with a high incidence of cardiovascular (CV) morbidity and mortality. Although relationships between hypertension and diabetic nephropathy are complex, blood pressure (BP) control is an important management strategy in the prevention of onset and progression of DN in patients with diabetes mellitus (DM). Recent guidelines recommend less stringent BP targets among patients with type 2 DM and chronic kidney disease. These recommendations are based mostly on lack of benefit in CV outcomes with a low BP target. We review the current information on efficacy of BP control in improving renal outcomes in patients with type 2 DM. Presently, although intensive BP control has been was beneficial in decreasing albuminuria, it has not translated into reductions in risks of hard renal endpoints, such as progression to end-stage renal disease, the need for renal replacement therapy, and mortality from renal causes.

Entities:  

Mesh:

Year:  2015        PMID: 25990743     DOI: 10.1007/s11892-015-0613-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  155 in total

1.  Natural course and prognosis of juvenile diabetes.

Authors:  P WHITE
Journal:  Diabetes       Date:  1956 Nov-Dec       Impact factor: 9.461

2.  Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.

Authors:  S Nielsen; A Schmitz; P L Poulsen; K W Hansen; C E Mogensen
Journal:  Diabetes Care       Date:  1995-11       Impact factor: 19.112

3.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

4.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

5.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

6.  Heterogeneous nature of renal lesions in type II diabetes.

Authors:  V Gambara; G Mecca; G Remuzzi; T Bertani
Journal:  J Am Soc Nephrol       Date:  1993-02       Impact factor: 10.121

Review 7.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

8.  In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

Authors:  Bruce A Perkins; Linda H Ficociello; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2010-01       Impact factor: 10.612

9.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

10.  Observation on renal outcomes in the Veterans Affairs Diabetes Trial.

Authors:  Lily Agrawal; Nasrin Azad; Nicholas V Emanuele; Gideon D Bahn; Derrick G Kaufman; Thomas E Moritz; William C Duckworth; Carlos Abraira
Journal:  Diabetes Care       Date:  2011-07-20       Impact factor: 19.112

View more
  4 in total

1.  The Effects of Probiotic Honey Consumption on Metabolic Status in Patients with Diabetic Nephropathy: a Randomized, Double-Blind, Controlled Trial.

Authors:  Navid Mazruei Arani; Zahra Emam-Djomeh; Hamid Tavakolipour; Reza Sharafati-Chaleshtori; Alireza Soleimani; Zatollah Asemi
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

2.  Racial differences in nocturnal dipping status in diabetic kidney disease: Results from the STOP-DKD (Simultaneous Risk Factor Control Using Telehealth to Slow Progression of Diabetic Kidney Disease) study.

Authors:  Leah L Zullig; Clarissa J Diamantidis; Hayden B Bosworth; Manjushri V Bhapkar; Huiman Barnhart; Megan M Oakes; Jane F Pendergast; Julie J Miller; Uptal D Patel
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08-20       Impact factor: 3.738

3.  Eighth Joint National Committee (JNC-8) Guidelines and the Outpatient Management of Hypertension in the African-American Population.

Authors:  Nicole Abel; Krysta Contino; Navjot Jain; Navjot Grewal; Elizabeth Grand; Iris Hagans; Krystal Hunter; Satyajeet Roy
Journal:  N Am J Med Sci       Date:  2015-10

4.  A Study of Association of Urinary Nephrin with Albuminuria in Patients with Diabetic Nephropathy.

Authors:  Kishore Kondapi; N Lakshmana Kumar; Swathi Moorthy; Santhi Silambanan
Journal:  Indian J Nephrol       Date:  2021-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.